The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...
This is a $248,971.98 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of Luminex Beads, with no set-aside designation. Luminex is a prime contractor that provides specialized multiplex diagnostic platforms, assays, reagents, and services to federal agencies including the CDC, VA, DHA,...
The Centers for Disease Control and Prevention (CDC) awarded a $79,711 firm-fixed-price purchase order contract to Luminex Corporation for annual services. The contract has an ultimate completion date of April 30, 2026. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions, and often serves as a prime contractor delivering specialized multiplexing systems to federal agencies. This contract is not designated as a set-aside requirement. Luminex...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies and diagnostic solutions, for LUMINEX 200 SERVICE. The $23,850.00 contract has a ceiling value and an ultimate completion date of July 7, 2027. This award does not utilize a set-aside mechanism. Luminex Corp, a foreign-owned, for-profit manufacturer, has provided specialized multiplexing systems, assay kits, reagents, and...
This is a $54,350.44 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the procurement of Luminex's proprietary MagPlex-C Microsphere Beads, which are a specialized laboratory instrument used in the CDC's serological assays to quantify antibodies for public health surveillance. The CDC requires these beads due to their...
This is a firm fixed-price purchase order issued by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies. The contract, valued at $95,567.12, is for the procurement of Luminex Microspheres. Luminex often serves as a prime contractor for the CDC, Department of Veterans Affairs, Department of Defense, and other federal agencies, providing specialized multiplexing systems and diagnostic testing products. While this award does...
This is a $148,245 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luminex Corp, a manufacturer of biological testing technologies, for the XTAG Gastrointestinal Pathogen Panel. The contract is not associated with a set-aside program. Luminex provides multiplex diagnostic solutions, assay kits, reagents, and related products to support clinical testing and biomedical research programs across federal agencies...
The Centers for Disease Control and Prevention (CDC) awarded Luminex Corporation a $101,651.60 purchase order contract for laboratory supplies. The contract has a period of performance from September 21, 2023 through November 1, 2024. Luminex will provide the supplies to support CDC programs in Pittsburgh, Pennsylvania on a firm fixed price basis. No subcontractors or set aside designations were identified. The CDC works to protect public health and safety through the control and prevention of...